Printer Friendly

iBio Inc names Arthur Y Elliott PhD to board.

M2 EQUITYBITES-6 August 2010-iBio Inc names Arthur Y Elliott PhD to board(C)2010 M2 COMMUNICATIONS

Biotech company iBio Inc (OTCBB:IBPM) stated on Thursday the appointment of Arthur Y Elliott PhD to the board of directors of the company.

Dr Elliott, who is a distinguished infectious disease and vaccine manufacturing and licensing expert, brings the number of diverse professionals to seven, who will oversee the clinical trials and other commercialisation initiatives utilising the company's disruptive plant-based iBioLaunch technology platform proceed.

Currently, Dr Elliott serves as a member of the American Association for Advancement of Science, American Society for Microbiology and American Tissue Culture Association.

Most recently, he served as consultant to Aventis (Sanofi Pasteur) Pharmaceutical Corp.

Previously, Dr Elliott spent 16 years with Merck & Co, serving ultimately as executive director of Biological Operations, Merck Manufacturing Division. He was also employed as a biological consultant to the World Health Organisation, National Institutes of Health and The Bill & Melinda Gates Foundation.

((Comments on this story may be sent to

COPYRIGHT 2010 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Aug 6, 2010
Previous Article:Converted Organics Inc to introduce Turf Blend 6-0-0 in Martha's Vineyard Golf Club.
Next Article:Danish Cimber Sterling reports 11% passengers rise in Jul 2010.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters